Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

838 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjunctive agents to antipsychotics in schizophrenia: a systematic umbrella review and recommendations for amino acids, hormonal therapies and anti-inflammatory drugs.
Fond G, Mallet J, Urbach M, Benros ME, Berk M, Billeci M, Boyer L, Correll CU, Fornaro M, Kulkarni J, Leboyer M, Llorca PM, Misdrahi D, Rey R, Schürhoff F, Solmi M, Sommer IEC, Stahl SM, Pignon B, Berna F. Fond G, et al. Among authors: leboyer m. BMJ Ment Health. 2023 Oct;26(1):e300771. doi: 10.1136/bmjment-2023-300771. BMJ Ment Health. 2023. PMID: 37852631 Free PMC article.
Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial.
Strube W, Aksar A, Bauer I, Barbosa S, Benros M, Blankenstein C, Campana M, Davidovic L, Glaichenhaus N, Falkai P, Görlitz T, Hansbauer M, Heilig D, Khalfallah O, Leboyer M, Martinuzzi E, Mayer S, Moussiopoulou J, Papazova I, Perić N, Wagner E, Schneider-Axmann T, Simon J, Hasan A. Strube W, et al. Among authors: leboyer m. J Neural Transm (Vienna). 2023 Aug;130(8):1039-1048. doi: 10.1007/s00702-022-02566-6. Epub 2022 Nov 19. J Neural Transm (Vienna). 2023. PMID: 36401749 Free PMC article. Clinical Trial.
Physical and mental health status of former smokers and non-smokers patients with bipolar disorder.
Nobile B, Godin O, Gard S, Samalin L, Brousse G, Loftus J, Aubin V, Belzeaux R, Dubertret C, Le Strat Y, Mazer N, de Prémorel A, Roux P, Polosan M, Schwintzer T, Llorca PM; FondaMental Advanced Center of Expertise for Bipolar Disorders (FACE-BD) collaborators; Biseul I, Etain B, Moirand R, Olié E, Haffen E, Leboyer M, Courtet P, Guillaume S, Icick R. Nobile B, et al. Among authors: leboyer m. Acta Psychiatr Scand. 2023 Apr;147(4):373-388. doi: 10.1111/acps.13535. Epub 2023 Mar 1. Acta Psychiatr Scand. 2023. PMID: 36751870
Diurnal symptoms of sleepiness and dysfunction predict future suicidal ideation in a French cohort of outpatients (FACE-DR) with treatment resistant depression: A 1-year prospective study about sleep markers.
Maruani J, Molière F, Godin O, Yrondi A, Bennabi D, Richieri R, El-Hage W, Allauze E, Anguill L, Bouvard A, Camus V, Dorey JM, Etain B, Fond G, Genty JB, Haffen E, Holtzmann J, Horn M, Kazour F, Nguon AS, Petrucci J, Rey R, Stephan F, Vaiva G, Walter M; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR) Collaborators; Lejoyeux M, Leboyer M, Llorca PM, Courtet P, Aouizerate B, Geoffroy PA. Maruani J, et al. Among authors: leboyer m. J Affect Disord. 2023 May 15;329:369-378. doi: 10.1016/j.jad.2023.02.106. Epub 2023 Feb 24. J Affect Disord. 2023. PMID: 36842655
Clinical and pharmacological correlates of caffeine consumption in subjects with schizophrenia - Data from the FACE-SZ cohort.
Szoke A, Richard JR, Fond G, Misdrahi D, Lajnef M, Aouizerate B, Boyer L, Berna F, Capdevielle D, André M, Chereau I, Clauss-Kobayashi J, Coulon N, Dubertret C, Leignier S, Llorca PM, Mallet J, Passerieux C, Rey R, Schorr B, Urbach M, Leboyer M, Pignon B, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Szoke A, et al. Among authors: leboyer m. J Psychiatr Res. 2023 May;161:206-212. doi: 10.1016/j.jpsychires.2023.03.017. Epub 2023 Mar 13. J Psychiatr Res. 2023. PMID: 36934602
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study.
Fond G, Faugere M, Boyer L, Peri P, Stephan F, Moliere F, Anguill L, Bennabi D, Haffen E, Bouvard A, Walter M, Samalin L, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, Rey R, Horn M, Vaiva G, Hennion V, Etain B, El-Hage W, Camus V, Courtet P, Aouizerate B, Yrondi A, Lancon C, Richieri R. Fond G, et al. Among authors: leboyer m. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Aug 30;126:110779. doi: 10.1016/j.pnpbp.2023.110779. Epub 2023 Apr 27. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 37120004
Crossed clinical features between eating disorders and types of bipolar disorder: Results from the FondaMental Advanced Centers of Expertise - Bipolar Disorder cohort.
Flaudias V, Samalin L, Godin O, Gard S, Brousse G, Loftus J, Aubin V, Belzeaux R, Dubertret C, Le Strat Y, Mazer N, de Prémorel A, Roux P, Polosan M, Schwitzer T, Aouizerate B, Llorca PM; FondaMental Advanced Centers of Expertise for Bipolar Disorder (FACE-BD) collaborators; Biseul I, Etain B, Moirand R, Olié E, Haffen E, Leboyer M, Courtet P, Icick R, Guillaume S. Flaudias V, et al. Among authors: leboyer m. J Affect Disord. 2023 Aug 15;335:177-185. doi: 10.1016/j.jad.2023.05.017. Epub 2023 May 12. J Affect Disord. 2023. PMID: 37178826
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case-control study.
Sideli L, Aas M, Quattrone D, La Barbera D, La Cascia C, Ferraro L, Alameda L, Velthorst E, Trotta G, Tripoli G, Schimmenti A, Fontana A, Gayer-Anderson C, Stilo S, Seminerio F, Sartorio C, Marrazzo G, Lasalvia A, Tosato S, Tarricone I, Berardi D, D'Andrea G; EU-GEI WP2 Group; Arango C, Arrojo M, Bernardo M, Bobes J, Sanjuán J, Santos JL, Menezes PR, Del-Ben CM, Jongsma HE, Jones PB, Kirkbride JB, Llorca PM, Tortelli A, Pignon B, de Haan L, Selten JP, Van Os J, Rutten BP, Bentall R, Di Forti M, Murray RM, Morgan C, Fisher HL. Sideli L, et al. Soc Psychiatry Psychiatr Epidemiol. 2023 Oct;58(10):1573-1580. doi: 10.1007/s00127-023-02513-0. Epub 2023 Jun 19. Soc Psychiatry Psychiatr Epidemiol. 2023. PMID: 37335320 Free PMC article.
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study.
Rodríguez-Toscano E, Alloza C, Fraguas D, Durán-Cutilla M, Roldán L, Sánchez-Gutiérrez T, López-Montoya G, Parellada M, Moreno C, Gayer-Anderson C, Jongsma HE, Di Forti M, Quattrone D, Velthorst E, de Haan L, Selten JP, Szöke A, Llorca PM, Tortelli A, Bobes J, Bernardo M, Sanjuán J, Luis Santos J, Arrojo M, Tarricone I, Berardi D, Ruggeri M, Lasalvia A, Ferraro L, La Cascia C, La Barbera D, Menezes PR, Del-Ben CM; EU-GEI WP2 Group; Rutten BP, van Os J, Jones PB, Murray RM, Kirkbride JB, Morgan C, Díaz-Caneja CM, Arango C. Rodríguez-Toscano E, et al. Schizophr Bull. 2023 Sep 7;49(5):1269-1280. doi: 10.1093/schbul/sbad013. Schizophr Bull. 2023. PMID: 37467351
Indirect effect of impulsivity on suicide risk through self-esteem and depressive symptoms in a population with treatment-resistant depression: A FACE-DR study.
Salles J, Stephan F, Molière F, Bennabi D, Haffen E, Bouvard A, Walter M, Allauze E, Llorca PM, Genty JB, Leboyer M, Holtzmann J, Nguon AS, D'Amato T, Rey R, Horn M, Vaiva G, Fond G, Richieri R, Hennion V, Etain B, El-Hage W, Camus V; FondaMental Advanced Centers of Expertise in Resistant Depression (FACE-DR) collaborators; Courtet P, Aouizerate B, Yrondi A. Salles J, et al. Among authors: leboyer m. J Affect Disord. 2024 Feb 15;347:306-313. doi: 10.1016/j.jad.2023.11.063. Epub 2023 Nov 20. J Affect Disord. 2024. PMID: 37992775
838 results